Michael D Dake
Overview
Explore the profile of Michael D Dake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
2273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Powell R, Farber A, Doros G, Chew D, Conte M, Dake M, et al.
J Vasc Interv Radiol
. 2025 Feb;
PMID: 40015448
Purpose: To analyze the causes and clinical impacts of endovascular technical failure (ETF) in the BEST-CLI trial, which compared endovascular therapy to bypass surgery in patients with chronic limb-threatening ischemia...
2.
Malas M, Hamouda M, Farber A, Menard M, Conte M, Rosenfield K, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39846933
Background: Chronic limb-threatening ischemia (CLTI) in patients with chronic kidney disease (CKD) has a high risk of poor outcomes. We aimed to compare the outcomes of lower extremity revascularization in...
3.
Wang G, Desai N, Bavaria J, Kasner S, Patel H, Dake M
Ann Vasc Surg
. 2024 Oct;
110(Pt A):447-459.
PMID: 39424183
Background: The GORE® TAG® Thoracic Branch Endoprosthesis is the only currently Food and Drug Administration-approved branched device for the treatment of thoracic aortic pathology requiring landing in Zone 2 in...
4.
Ochoa Chaar C, Malas M, Doros G, Schermerhorn M, Conte M, Alameddine D, et al.
J Vasc Surg
. 2024 Sep;
81(2):376-385.e3.
PMID: 39332785
Objective: Several observational studies have demonstrated an association between diabetes mellitus (DM) and above-ankle amputation after lower extremity revascularization (LER). However, data from prospective randomized trials is lacking. This analysis...
5.
Menard M, Farber A, Doros G, McGinigle K, Chisci E, Clavijo L, et al.
J Vasc Surg
. 2024 Jul;
80(6):1755-1765.e4.
PMID: 39069016
Objective: Sustained clinical and hemodynamic benefit after revascularization for chronic limb-threatening ischemia (CLTI) is needed to resolve symptoms and prevent limb loss. We sought to compare rates of clinical and...
6.
Suh G, Hirotsu K, Beygui R, Dake M, Fleischmann D, Cheng C
J Vasc Surg Cases Innov Tech
. 2024 Jun;
2(3):101-104.
PMID: 38827208
A 62-year-old man underwent an elephant trunk procedure followed by thoracic endovascular aortic repair (TEVAR). Computed tomography angiography-based models were built to quantify volume of the whole aorta and true...
7.
Menard M, Farber A, Powell R, Rosenfield K, Conte M, Hamza T, et al.
Circulation
. 2024 Apr;
149(16):1241-1253.
PMID: 38597097
Background: In the BEST-CLI trial (Best Endovascular Versus Best Surgical Therapy for Patients With Chronic Limb-Threatening Ischemia), a prespecified secondary objective was to assess the effects of revascularization strategy on...
8.
Chou E, Lu E, Dake M, Fischbein M, Bavaria J, Oderich G, et al.
Ann Vasc Surg
. 2024 Mar;
104:147-155.
PMID: 38492730
Background: Endovascular repair of blunt thoracic aortic injury (BTAI) has dramatically reduced the morbidity and mortality of intervention. Injuries requiring zone 2 coverage of the aorta traditionally require left subclavian...
9.
LaFleur B, White L, Dake M, Nikolich J, Sprissler R, Bhattacharya D
Immunohorizons
. 2023 Dec;
7(12):834-841.
PMID: 38085168
Uptake of mRNA vaccines, especially booster immunizations, against COVID-19 has been lower than hoped, perhaps in part due to their reactogenicity. Analgesics might alleviate symptoms associated with vaccination, but they...
10.
Matsumoto A, Dake M
J Vasc Interv Radiol
. 2023 Nov;
34(12):2080-2084.
PMID: 38008543
The recent awarding of primary specialty status to interventional radiology (IR) invites a re-examination of the long-standing relationship between IR and diagnostic radiology (DR). In this new era, it is...